Published in J Infect on March 25, 2010
Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med (2014) 0.85
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin. Infect Drug Resist (2011) 0.79
Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis. Eur J Clin Microbiol Infect Dis (2012) 0.78
OPAT for cellulitis: its benefits and the factors that predispose to longer treatment. Eur J Clin Microbiol Infect Dis (2016) 0.75
Clinical, diagnostic, and therapeutic features of patients admitted to acute care hospitals with trunk compared to lower limb cellulitis. Intern Emerg Med (2017) 0.75
Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis (2017) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A (1990) 4.59
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer (2011) 1.86
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys (2001) 1.70
Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol (1991) 1.68
Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase. FEBS Lett (1971) 1.63
Relative impact of oxidative stress on the functional competence and genomic integrity of human spermatozoa. Biol Reprod (1998) 1.47
Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer (2012) 1.45
Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin. J Am Coll Cardiol (1990) 1.44
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer (2005) 1.42
Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet (1986) 1.34
Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol (1989) 1.29
Purification of antiphospholipid antibodies using a new affinity method. Thromb Res (1988) 1.15
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med (1990) 1.13
Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol (1996) 1.12
MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. Eur J Clin Microbiol Infect Dis (2008) 1.04
Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc Natl Acad Sci U S A (1993) 1.04
Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill (2012) 1.03
Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J Biol Chem (1999) 1.02
Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J Immunol (1996) 1.00
Impaired thrombin generation in beta 2-glycoprotein I null mice. J Biol Chem (2001) 1.00
Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells. J Biol Chem (2001) 0.99
Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost (2010) 0.98
A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer (2001) 0.98
Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources. J Autoimmun (2000) 0.98
Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem (1999) 0.98
Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol (1995) 0.95
Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost (2008) 0.95
Risk perception is affected by modes of risk presentation among Singaporeans. Ann Acad Med Singapore (2005) 0.94
Binding specificity of lupus anticoagulants and anticardiolipin antibodies. Thromb Res (1988) 0.93
Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol (2005) 0.92
Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Clin Exp Immunol (2001) 0.92
Antiphospholipid antibodies--new insights into their specificity and clinical importance. Scand J Immunol (1992) 0.90
Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma. Cytokine (2007) 0.89
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect (2010) 0.88
Beta 2-glycoprotein I. Lupus (1994) 0.88
Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J Immunol (1998) 0.88
Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects. Adv Immunol (1998) 0.87
The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study. Rheumatology (Oxford) (2005) 0.87
A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope (1999) 0.87
Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese). Ann Acad Med Singapore (2003) 0.87
Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost (2002) 0.86
Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I. J Thromb Haemost (2011) 0.86
In vivo modulation of angiogenesis by beta 2 glycoprotein I. J Autoimmun (2010) 0.86
Small bowel mucosa from celiac patients generates 15-hydroxyeicosatetraenoic acid (15-HETE) after in vitro challenge with gluten. J Immunol (1986) 0.84
A topical nitric oxide-generating therapy for cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (2000) 0.84
beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'. Lupus (1996) 0.84
Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer. Tumour Biol (2001) 0.83
Tryptase 4, a new member of the chromosome 17 family of mouse serine proteases. J Biol Chem (2001) 0.83
The use of midazolam and haloperidol in cancer patients at the end of life. Singapore Med J (2012) 0.83
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levels. Eur J Clin Invest (1992) 0.83
New aspects of anticardiolipin antibodies. Clin Exp Rheumatol (1991) 0.82
Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndrome. Clin Exp Rheumatol (1998) 0.82
Mast-cell growth and differentiation. Allergy (1999) 0.82
Antiphospholipid antibodies. Aust N Z J Med (1991) 0.82
Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells. Lupus (1998) 0.81
Quick-FLIC: validation of a short questionnaire for assessing quality of life of cancer patients. Br J Cancer (2004) 0.81
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers. Ann Oncol (2011) 0.81
High energy focused shock wave therapy accelerates bone healing. A blinded, prospective, randomized canine clinical trial. Vet Comp Orthop Traumatol (2015) 0.80
Anti-beta2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding. Lupus (2003) 0.80
Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy. Neuroscience (2012) 0.80
Testing for and clinical significance of anticardiolipin antibodies. Clin Diagn Lab Immunol (1999) 0.80
Validation of the English and Chinese versions of the Quick-FLIC quality of life questionnaire. Br J Cancer (2005) 0.80
The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer (2000) 0.80
Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium. Blood (1986) 0.80
Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism. Br J Urol (1990) 0.79
Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome. Thromb Haemost (1998) 0.79
Is there room for general practice in penitentiary institutions: screening and vaccinating high-risk groups against hepatitis. Fam Pract (1999) 0.79
Acute fluoride poisoning. Pediatrics (1976) 0.79
Conditioned media obtained from a human mastocytosis cell strain induce mast cells expressing chymase but not tryptase from human progenitors. Int Arch Allergy Immunol (1997) 0.79
Hyperamylasaemia in asymptomatic HIV patients. Ann Clin Biochem (1997) 0.79
Study of cell-free protein synthesis in aqueous two-phase systems. J Mol Recognit (1995) 0.78
Use of various methods for anticardiolipin detection in the updated American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: comment on the letter by Hochberg. Arthritis Rheum (1998) 0.78
Polymorphisms of Cx(3)CR1 and CXCR6 receptors in relation to HAART therapy of HIV type 1 patients. AIDS Res Hum Retroviruses (2007) 0.78
HLA-DR antigens and anticardiolipin antibodies. Clin Exp Rheumatol (1990) 0.78
Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Clin Exp Immunol (1989) 0.78
Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles. Lupus (1998) 0.78
Modulation of endothelial cell function by antiphospholipid antibodies. Lupus (1996) 0.78
Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. J Immunol (1996) 0.77
Emergency department usage by community step-down facilities--patterns and recommendations. Ann Acad Med Singapore (2003) 0.77
Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects. Lupus (1998) 0.77
Conditioned medium from a cell strain derived from a patient with mastocytosis induces the development of mature human mast cells in vitro from normal human bone marrow. Int Arch Allergy Immunol (1995) 0.77
Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks? Intern Med J (2013) 0.77
Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels. Autoimmunity (1993) 0.76
Reversible immobilization of antibodies on magnetic beads. Anal Biochem (1992) 0.76
Vaccination against 2009 pandemic H1N1 influenza among healthcare workers in a tertiary hospital: rates, reasoning, beliefs. J Hosp Infect (2011) 0.75
Bioprofiling over grid for eHealthcare. Stud Health Technol Inform (2006) 0.75
Antiphospholipid antibodies, beta 2-glycoprotein I and thrombosis. Lupus (1993) 0.75
Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis. Clin Nephrol (1994) 0.75
New basic aspects of the antiphospholipid syndrome. Clin Exp Rheumatol (1995) 0.75
Cloning and characterization of the gene encoding the mouse beta 2-glycoprotein I. Genomics (1997) 0.75
Production and characterization of antibodies to platelet-activating factor. J Lipid Mediat (1992) 0.75
Accuracy of a radiographic stitching technique to measure tibial plateau angle in large and giant breed dogs. Vet Comp Orthop Traumatol (2014) 0.75